Recent advances in artificial intelligence have enabled a new generation of companies and products that are poised to change healthcare forever. From drug discovery to early disease detection, AI is shaping a future where care is personalized, preemptive, and affordable.
Biocogniv enables a key part of this future by combining laboratory medicine, state-of-the-art AI, and evidence-based acute care, to reduce preventable hospital deaths, morbidities, and cost of care.
Biocogniv enables a key part of this future by combining laboratory medicine, state-of-the-art AI, and evidence-based acute care, to reduce preventable hospital deaths, morbidities, and cost of care.
Location: United States, Vermont, South Burlington
Employees: 1-10
Total raised: $2.7M
Founded date: 2019
Investors 5
Date | Name | Website |
- | Hula | hulalakesi... |
25.03.2022 | Breyer Cap... | breyercapi... |
08.04.2021 | Y Combinat... | ycombinato... |
- | 1984 Ventu... | 1984.vc |
- | Inflect He... | inflecthea... |
Funding Rounds 1
Date | Series | Amount | Investors |
31.08.2020 | Seed | $2.7M | - |
Mentions in press and media 2
Date | Title | Description |
27.07.2022 | Biocogniv Powers UTMB’s Award-Winning COVID-19 Program | University of Texas Medical Branch pathologists increased throughput & lab interpretation volumes using Biocogniv’s interpAssist™, leading to a 2022 Gage Award. Biocogniv’s technology helps UTMB pathologists increase throughput and volu... |
27.08.2020 | Here are the 197 tech startups from Y Combinator’s Summer 2020 Batch | We wrote about Y Combinator (YC) back in June after the startup incubator relaunched its Startup School as a Continuous Program. Y Combinator is a startup incubator that provides funding for early-stage startups. Since its inception in 2005... |